Literature DB >> 12130477

CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall.

Haifa-Kathria Al-Ali, Sabine Leiblein, Ines Kovacs, Evelin Hennig, Dietger Niederwieser, Michael W N Deininger.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12130477     DOI： 10.1182/blood-2002-03-0930

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  14 in total

1.  A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.

Authors:  Masayoshi Masuko; Tatsuo Furukawa; Takashi Abe; Reiko Wada; Soichi Maruyama; Toshiki Kitajima; Yasuhiko Shibasaki; Ken Toba; Masahiko Okada; Yoshifusa Aizawa
Journal:  Int J Hematol       Date:  2009-06-30       Impact factor: 2.490

2.  Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.

Authors:  Sarah L McCarron; Stephen E Langabeer; Karen Bolger; Karl Haslam; Mireille Crampe; Johanna Kelly; Ruth Morrell
Journal:  Med Oncol       Date:  2015-01-13       Impact factor: 3.064

3.  A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practice.

Authors:  Natini Jinawath; Alexis Norris-Kirby; B Douglas Smith; Christopher D Gocke; Denise A Batista; Constance A Griffin; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2009-06-04       Impact factor: 5.568

4.  A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes.

Authors:  Walid Al Achkar; Abdulsamad Wafa; Bashar Yousef Ali; Marina Manvelyan; Thomas Liehr
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

Review 5.  Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia.

Authors:  Michael W N Deininger
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-07       Impact factor: 4.553

Review 6.  A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature.

Authors:  Shinya Fujisawa; Satoki Nakamura; Kensuke Naito; Masahide Kobayashi; Kazunori Ohnishi
Journal:  Int J Hematol       Date:  2008-02-06       Impact factor: 2.490

Review 7.  Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.

Authors:  Afaf E G Osman; Michael W Deininger
Journal:  Blood Rev       Date:  2021-03-16       Impact factor: 10.626

8.  Optimal Molecular Methods in Detecting p190 (BCR-ABL) Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature.

Authors:  Rebecca J Sonu; Brian A Jonas; Denis M Dwyre; Jeffrey P Gregg; Hooman H Rashidi
Journal:  Case Rep Hematol       Date:  2015-04-08

9.  Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis.

Authors:  Jordi Martinez-Serra; Raquel Del Campo; Antonio Gutierrez; Jose Luis Antich; Magdalena Ginard; Maria A Durán; Leyre Bento; Teresa Ros; Juan C Amat; Carmen Vidal; Julio F Iglesias; Izabela Orlinska; Joan Besalduch
Journal:  Biomark Res       Date:  2014-08-14

10.  Frequency of BCR-ABL Transcript Types in Syrian CML Patients.

Authors:  Sulaf Farhat-Maghribi; Wafa Habbal; Fawza Monem
Journal:  J Oncol       Date:  2016-05-30       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.